Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

10X Genomics Inc (NQ: TXG )

41.91 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about 10X Genomics Inc

< Previous 1 2 3 4 5 Next >
Where 10x Genomics Stands With Analysts
Via Benzinga
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
Via Benzinga
Market Rally Under Pressure As Yields Soar; Amazon, ELF, Caterpillar Are Earnings Winners: Weekly Review
Amazon, ELF and CAT were earnings winners, but there were big losers too. 
Via Investor's Business Daily
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. 
Via Benzinga
Earnings Outlook For 10x Genomics
Via Benzinga
Where 10x Genomics Stands With Analysts
Via Benzinga
Looking Into 10x Genomics's Return On Capital Employed
Via Benzinga
Buy-Zone-Adjacent 10x Genomics Tops Sales Views, But There's A Caveat
The company is working in the nascent research area of spatial biology, which could unlock the answers to some diseases. 
Via Investor's Business Daily
10x Genomics Inc. (NASDAQ: TXG) Sets New 52-Week High in Thursday Session
Via Investor Brand Network
Brace for Impact: These 5 Overvalued Stocks Face Bearish Pressure In Impending Market Reversal
Via Benzinga
Cathie Wood Is Buying the SEC Lawsuit Dip in Coinbase (COIN) Stock
Coinbase and the crypto industry at large is at war with regulators. But Cathie Wood is still buying shares of COIN stock. 
Via InvestorPlace
7 Analysts Have This to Say About 10x Genomics
Via Benzinga
Why Are NanoString Technologies Shares Falling Today
Wednesday, 10x Genomics Inc (NASDAQ: TXG) won an injunction in its patent litigation against NanoString Technologies Inc (NASDAQ: NSTG) and its German subsidiary regarding CosMx  
Via Benzinga
10x Genomics: Q1 Earnings Insights
Via Benzinga
Earnings Preview: 10x Genomics
Via Benzinga
Elliott Wave Technical Analysis:10X Genomics Inc.
Looking for short-term shorts as we should start to unfold lower. ​​​​​​ 
Via Talk Markets
Analyst Expectations for 10x Genomics's Future
Via Benzinga
Why Shares of NanoString Technologies Are Falling Thursday
The company lost a patent ruling in Germany to life sciences competitor 10x Genomics. 
Via The Motley Fool
3 DNA Stocks to Buy for the Synthetic Biology Revolution
Synthetic biology is a growing industry. The big winners will be DNA stocks that are able to sell to everyone, not just a small niche. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
Via Benzinga
Elliott Wave Technical Analysis: 10x Genomics
Looking for upside resumption soon or else the count will be invalidated. 
Via Talk Markets
KBR, Twilio, Roku And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
3 CRISPR Stocks to Buy Now Or You’ll Be Kicking Yourself Later
CRISPR stocks are heating back up after a difficult 2022. These three names should be at the top of your watchlist. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2023
Via Benzinga
10x Genomics Earnings Perspective: Return On Capital Employed
Via Benzinga
10x Genomics's Return On Capital Employed Insights
Via Benzinga
Elliott Wave Technical Analysis: 10x Genomics Inc.
It looks like we are extending higher into wave {iii}, looking for additional longs into wave {v}. 
Via Talk Markets
These Were The Five Best And Worst Performing Mid-Cap Stocks In November 2022
In November, the Dow Jones gained around 7%, the S&P 500 gained 8.4%, and the Nasdaq gained 9.1%. The S&P Mid-Cap 400 performance was in line with major indices. Let’s take a look at the five best and... 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.